Pure Global

LIAISON® Β2-MICROGLOBULIN - COFEPRIS Registration 2207R2019 SSA

Access comprehensive regulatory information for LIAISON® Β2-MICROGLOBULIN (LIAISON® B2-MICROGLOBULIN) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2207R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on December 04, 2019.

This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase I
2207R2019 SSA
LIAISON® Β2-MICROGLOBULIN
COFEPRIS Analysis ID: 2207R2019 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

ENSAYO IN VITRO PARA LA DETERMINACIÓN CUANTITATIVA DE Β2-MICROGLOBULINA (B2M)

English

IN VITRO TEST FOR THE QUANTITATIVE DETERMINATION OF Β2-MICROGLOBULIN (B2M)

Device Classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. AGENTES DE DIAGNÓSTICO
Product Type (English)
III. DIAGNOSTIC AGENTS
Trade Name (Spanish)
ENSAYO IN VITRO PARA LA DETERMINACIÓN CUANTITATIVA DE Β2-MICROGLOBULINA (B2M)
Trade Name (English)
IN VITRO TEST FOR THE QUANTITATIVE DETERMINATION OF Β2-MICROGLOBULIN (B2M)
Registration Information
Analysis ID
2207R2019 SSA
Registration Date
December 04, 2019
Manufacturer / Fabricante
Name (English)
DIASORIN MEXICO S.A. DE C.V.